Enter multiple symbols separated by commas

Search results for "WPI"



About 30 results. Sort By: Date | Relevance
EXCLUSIVE-Hedge fund mogul Paulson: Gold is now 'fairly valued'

Paulson, in his first public comments since the recent price crash, said his firm, Paulson& Co. Inc., has retained a 10 million share stake, now worth about $1 billion, in SPDR Gold Trust, which tracks the price of gold. While Paulson's hedge fund was the single largest investor in the SPDR Gold Trust at the end of the first quarter, the position, now worth about $1.05...
Source: Reuters | By: Svea Herbst-Bayliss
Healthcare deals lift July to 7th busiest M&A month on record

LONDON, July 31- A surge of takeover activity involving healthcare, financial and retail companies lifted the value of deals in July over $430 billion, making it the seventh-busiest mergers and acquisition month on record, Thomson Reuters data showed. JPMorgan- in second place- advised on 30 deals with a value of $116.1 billion, and third-ranked Morgan Stanley...
Source: Reuters
Former Allergan CEO is still going after Pershing

Former Allergan CEO David Pyott tells a Senate hearing the SEC should investigate the Pershing Square-Valeant alliance.
Source: CNBC.com | By: Meg Tirrell
Teva's MS drug Copaxone has strong second-quarter sales

JERUSALEM, July 30- Teva Pharmaceutical Industries, which this week revealed plans to buy Allergan's generics drugs business in a $40.5 billion deal, said on Thursday sales of its branded multiple sclerosis drug Copaxone rose 12 percent in the second quarter even though it faces new competition. Teva, the world's biggest generic drug maker, said that global...
Source: Reuters
Mylan gets European clearance in proposed Perrigo takeover

NEW YORK- Mylan NV said Wednesday that it received European regulatory approval to move forward with its proposed buyout of Perrigo Co., which has resisted repeated overtures. In April, the generic drugmaker raised its offer for Perrigo to $232.23, or about $34.1 billion, in cash and stock. But Dublin- based Perrigo, which makes over-the-counter medicines, once...
Source: The Associated Press
RPT-Mylan independence from Teva's embrace comes with a price

Mylan, whose shares fell 14.5 percent, said it would continue its own unsolicited pursuit of Irish drugmaker Perrigo Co, a maker of over-the-counter consumer and nutritional products and generic topical medicines. Perrigo is one of the few remaining assets out there, "said Morningstar analyst Michael Waterhouse. Other industry analysts expect Mylan will...
Source: Reuters | By: Bill Berkrot
UPDATE 1-Allergan CEO, fresh off one deal, sets sights on others

NEW YORK, July 27- Allergan plc CEO Brent Saunders is ready to put the $36 billion his company will net from the sale of its generics business to Teva Pharmaceutical Industries Ltd to work, possibly with another large, "transformational" merger. As head of Actavis, he then sealed a $66 billion purchase of Botox-maker Allergan, beating out rival suitor Valeant...
Source: Reuters | By: Caroline Humer
US STOCKS-Wall St drops as China stock slump stokes growth fears

*Oil prices, commodities lower following China equity selloff. *Teva, Allergan jump after $40.5 bln deal. U.S.-listed shares of Chinese companies slid, including Alibaba and Baozun.
Source: Reuters | By: Noel Randewich
Teva and Restaurant Brands are big market movers

NEW YORK- Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:. Teva Pharmaceuticals Industries Ltd., up $10.15 to $72. Restaurant Brands International Inc., up $1.41 to $41.50.
Source: The Associated Press
Analysts expect more tie-ups in generic drug business

The Dutch drugmaker Mylan, which had resisted Teva's advances for three months, is pressing ahead with its offer for Irish drug and ingredients maker Perrigo. Perrigo has turned down Mylan's offer. If they can't work it out, Perrigo might find other suitors as the competitive generic drug industry keeps consolidating.
Source: The Associated Press